LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

LLY

748.08

-0.86%↓

JNJ

177.42

-0.37%↓

ABBV

217.75

-0.25%↓

UNH

347.95

-1.4%↓

AZN

78.06

-1.86%↓

Search

Durect Corp

Abrir

1.92 -0.52

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.92

Máximo

1.92

Indicadores-chave

By Trading Economics

Funcionários

13

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+17.8% upside

Dividendos

By Dow Jones

Próximos Ganhos

12 de nov. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

2.2M

53M

Abertura anterior

2.44

Fecho anterior

1.92

Durect Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

12 de set. de 2025, 22:41 UTC

Grandes Movimentos do Mercado

GlucoTrack Stock Falls on Plans to Sell $3 Million Note

12 de set. de 2025, 16:04 UTC

Grandes Movimentos do Mercado

Upexi Shares Climb on Solana Gains

14 de set. de 2025, 23:48 UTC

Conversa de Mercado

Oil Futures Mixed Amid Divergent Signals -- Market Talk

14 de set. de 2025, 23:41 UTC

Conversa de Mercado

Gold Edges Lower on Likely Technical Correction -- Market Talk

14 de set. de 2025, 23:38 UTC

Conversa de Mercado

China's Economic Activity Data May Continue Reflecting Slowdown -- Market Talk

14 de set. de 2025, 23:13 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

14 de set. de 2025, 23:13 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

14 de set. de 2025, 23:13 UTC

Conversa de Mercado

Infratil May Need to Be More Aggressive With Asset Sales -- Market Talk

14 de set. de 2025, 23:13 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

14 de set. de 2025, 23:04 UTC

Conversa de Mercado

Aristocrat's Interactive Unit Appears in Safe Hands -- Market Talk

13 de set. de 2025, 08:20 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

12 de set. de 2025, 20:50 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

12 de set. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

12 de set. de 2025, 20:09 UTC

Ganhos

Correction to Opendoor Is Sliding. Don't Call It a Meme Stock, Says New Chairman. -- Barrons.com

12 de set. de 2025, 19:23 UTC

Conversa de Mercado

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12 de set. de 2025, 19:16 UTC

Conversa de Mercado

Oil Futures End Volatile Week With Moderate Gains -- Market Talk

12 de set. de 2025, 19:03 UTC

Conversa de Mercado

Natural Gas Futures Held Back By Plump Inventories -- Market Talk

12 de set. de 2025, 18:59 UTC

Conversa de Mercado

Dollar Pares Gains as Economy Keeps Showing Signs of Cooling -- Market Talk

12 de set. de 2025, 18:38 UTC

Conversa de Mercado
Ganhos

Adobe Seen Reaching Turning Point in AI Cycle -- Market Talk

12 de set. de 2025, 18:33 UTC

Conversa de Mercado

U.S. Oil Rig Count Rises By 2 to 416 -- Market Talk

12 de set. de 2025, 18:22 UTC

Conversa de Mercado

Canada's Divergence With US On Capex Spending is 'Appalling' -- Market Talk

12 de set. de 2025, 16:56 UTC

Conversa de Mercado

Renewable Fuels Association Calls for Nationwide E15 Following WASDE -- Market Talk

12 de set. de 2025, 16:22 UTC

Ganhos

Adobe Earnings Were 'Solid.' Long-Term Growth Concerns Remain. -- Barrons.com

12 de set. de 2025, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

12 de set. de 2025, 16:19 UTC

Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

12 de set. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

12 de set. de 2025, 16:11 UTC

Ganhos

Novartis Catches a 'Sell.' Goldman Sachs Says the Stock Is Overvalued. -- Barrons.com

12 de set. de 2025, 15:37 UTC

Conversa de Mercado

Gold Holds Near All-Time Highs Ahead of Fed Meeting Next Week -- Market Talk

12 de set. de 2025, 15:22 UTC

Conversa de Mercado

European Gas Lifted by Geopolitical Risks But Storage Levels Ease Supply Fears -- Market Talk

12 de set. de 2025, 15:07 UTC

Aquisições, Fusões, Aquisições de Empresas

These Stocks Are Moving the Most Today: Warner Bros., Paramount Skydance, Tesla, Super Micro, Microsoft, Figure Technology, and More -- Barrons.com

Comparação entre Pares

Variação de preço

Durect Corp Previsão

Preço-alvo

By TipRanks

17.8% parte superior

Previsão para 12 meses

Média 2.25 USD  17.8%

Máximo 2.5 USD

Mínimo 2 USD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para Durect Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

2 ratings

0

Comprar

2

Manter

0

Vender

Informação Financeira

$

Sobre Durect Corp

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
help-icon Live chat